Actimmune would fit the bill (controversial) but I believe it is no longer being tested in HCV (InterMune was testing it in combo with Infergen a couple years ago) unless I am behind on my news and Valient picked this up?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.